Bernie Sanders

Sanders Ahead of Vote to Subpoena CEOs to Testify on Outrageously High Prices of Prescription Drugs in America.

Merck has managed to extend its monopoly pricing power over Januvia through unfair patenting practices.

Be more aggressive in addressing the anxieties of millions of struggling voters, or risk handing back the White House to the anti-democratic demagogue Donald Trump.

We would be all in failure if we--if our children face a future pandemic and get hit with another long something--long virus in 2030 or something, and they don't know how to treat it.

This will not only help you address the issue of long COVID. It will also help us solve the puzzle of ME/CFS and all other infection associated chronic conditions that have been ignored for decades and help us prepare for the next pandemic.

We must address the challenge of Long Covid.

The U.S. should consider the establishment within the National Institutes of Health of an Institute for Infection-Associated Chronic Illnesses.

You have an historic opportunity to act. The lives of millions of Americans now and in the future depend on this.

We need a fundamental overhaul of our health care system with a Congress that is able to do it.

We know that long COVID can include more than 200 symptoms, including serious cognitive impairment and severe cardiovascular and neurological problems that can continue for weeks, months, or even years after initial infection.

This crisis is made even worse by the fact that long COVID patients often require multiple specialists to treat their complex symptoms.

The reality is we are going to hear from our panelists for a moment, is that long COVID is a very serious illness that can have devastating consequences for those who contract it in America today.

The symptoms of long COVID are not minor inconveniences. They are debilitating conditions that affect the ability of people to work, to care for their families, and to live full lives.

We think we have not, as a Congress, done anywhere near enough, and we hope to turn that around.

With enough political will, we can fund a Long COVID moonshot that transforms clinical and community care for all of us.

The PRESIDING OFFICER (Mr. Kelly). Is there a sufficient second? There appears to be a sufficient second.

I consider the high cost of prescription drugs to be one of the great crises facing our healthcare system.

Let me repeat, these two important drugs, up to 15 times more expensive in the United States than in other countries.

These drugs also have the potential to bankrupt Medicare and the American people.

I thank you Chairman Sanders, Ranking Member Dr. Cassidy, and Members of this Committee for advancing S. 1855--bipartisan legislation led by Senators Susan Collins and Jeanne Shaheen to renew the SDP and SDPI.

In order to do that, we must have the courage to take on the greed of the food and beverage industry, which every day is undermining the health and well-being of our children.

And if the system provides barriers, as Senator Sanders said, to drugs that could improve your care and your life and your health, then we haven't succeeded in our mission.

We are going to have to take on 1,800 well-paid lobbyists from the pharmaceutical industry here and all of the campaign contributions that they make.

We need Congress to move swiftly and enact the STP and STPI funding contained in S. 1855.

We have got to make certain that the treatments available to people with diabetes are affordable for all Americans and are not bankrupting Federal health insurance programs or raising the cost of private insurance.